Tianjin, China

Fuzhou Zhu


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fuzhou Zhu: Innovator in Metabolic Engineering

Introduction

Fuzhou Zhu is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of metabolic engineering, particularly in the production of L-leucine through genetically engineered bacteria. His innovative work has the potential to enhance the efficiency of amino acid production.

Latest Patents

Fuzhou Zhu holds a patent for "2-isopropylmalate synthetase and engineering bacteria and application thereof." This invention relates to a 2-isopropyl malate synthase and a genetically engineered bacterium designed for producing L-leucine. The bacterium is engineered by overexpressing specific coding genes to alleviate feedback inhibition, resulting in a strain that is nutritionally sufficient, grows rapidly, has a short fermentation period, and achieves high yield and conversion rates.

Career Highlights

Fuzhou Zhu is affiliated with Tianjin University of Science and Technology, where he continues to advance research in metabolic engineering. His work focuses on developing innovative solutions for amino acid production, which is crucial for various industrial applications.

Collaborations

Fuzhou Zhu collaborates with notable colleagues, including Chenglin Zhang and Qingyang Xu. Their combined expertise contributes to the advancement of research in metabolic engineering and the development of new biotechnological applications.

Conclusion

Fuzhou Zhu's contributions to metabolic engineering and his innovative patent for producing L-leucine highlight his role as a key inventor in this field. His work not only advances scientific knowledge but also has practical implications for industrial production processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…